Cyclotek and ANSTO to manufacture new radiopharmaceuticals
Cyclotek and ANSTO have announced the launch of a Joint Venture to establish Australia’s first GMP (Good Manufacturing Practice) theranostics production facility which will produce radiopharmaceuticals for both the diagnosis and treatment of cancer. The new company Applied Molecular Therapies Pty Ltd (AMT) will aim to establish a Therapeutic Goods Administration (TGA) approved, GMP manufacturing…











